Mark W. Hamblin

4.6k citations

41 papers · 3.9k indexed · 1 hit paper · h-index 29

Impact in

Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
Behavioral Neuroscience top 5%

Papers in

Cellular and Molecular Neuroscience 36
- Neurotransmitter Receptor Influence on Behavior 30
- Neuroscience and Neuropharmacology Research 16
Behavioral Neuroscience 3
- Stress Responses and Cortisol 3

Co-authors: David R. Sibley Mark A. Metcalf Ian Creese Frederick J. Monsma Stuart E. Leff Ruth Kohen Raymond P. Ward Yong Shen
Journals: Molecular Pharmacology (6 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Biological Psychiatry (3 papers)Brain Research (2 papers)Biochemical Pharmacology (2 papers)
Partner nations: United States Sweden Canada

In The Last Decade

Mark W. Hamblin

41 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. 1993 · 512 citations

Peers

Countries citing papers authored by Mark W. Hamblin

Since Specialization

Citations

This map shows the geographic impact of Mark W. Hamblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Hamblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Hamblin more than expected).

Fields of papers citing papers by Mark W. Hamblin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Hamblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Hamblin. The network helps show where Mark W. Hamblin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark W. Hamblin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Hamblin Line = papers co-authored together Mark W. Hamblin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cholesterol depletion reduces serotonin binding and signaling via human 5-HT7(a) receptors European Journal of Pharmacology ·Benita Sjögren, Mark W. Hamblin, Per Svenningsson	2006	53
2	Differential Agonist-Mediated Internalization of the Human 5-Hydroxytryptamine 7 Receptor Isoforms Journal of Pharmacology and Experimental Therapeutics ·Chris R. Guthrie, Sabrina Paris-Lacombe, Allyn Franklin, Mark W. Hamblin	2005	41
3	Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats The Pharmacogenomics Journal ·Ruth Kohen, Stefan Kirov, Martina Lucia Nied, H. Kevin Happe, Mark W. Hamblin, Jay Snoddy, John F. Neumaier, Frederick Petty	2005	35
4	Serotonergic Regulation of Membrane Potential in Developing Rat Prefrontal Cortex: Coordinated Expression of 5-Hydroxytryptamine (5-HT)_1A, 5-HT_2A, and 5-HT₇Receptors Journal of Neuroscience ·Jean-Claude Béïque, Brian Campbell, 卓示小田, Mark W. Hamblin, Paul D. Walker, Christophe Boltanski, Rodrigo Andrade	2004	154
5	Lack of association between the T→C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia Schizophrenia Research ·Mario Masellis, Vincenzo S. Basile, Herbert Y. Meltzer, Jeffrey A. Lieberman, Serge Sevy, David Goldman, Mark W. Hamblin, Fabìo Macciardi, James L. Kennedy	2001	66
6	Corticosteroids regulate 5-HT1A but not 5-HT1B receptor mRNA in rat hippocampus Molecular Brain Research ·John F. Neumaier, Timothy J. Sexton, Mark W. Hamblin, Sheryl G. Beck	2000	47
7	Changes in 5-HT7 serotonin receptor mRNA expression with aging in rat brain Molecular Brain Research ·Ruth Kohen, Doris Heidmann, مریم قایخلو, Sylvia S. White, Mark W. Hamblin, Patricia Szot	2000	14
8	Gs Protein‐Coupled Serotonin Receptors: Receptor Isoforms and Functional Differences Annals of the New York Academy of Sciences ·Mark W. Hamblin, Chris R. Guthrie, Ruth Kohen, Doris Heidmann	1998	23
9	Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7AReceptor Journal of Biological Chemistry ·Lauren P. Baker, Alice Cloe Soldavini, Soren Impey, Mark A. Metcalf, Steven Poser, Guy C.‐K. Chan, Karl Obrietan, Mark W. Hamblin, Daniel R. Storm	1998	80
10	Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus Biological Psychiatry ·John F. Neumaier, Frederick Petty, Gerald L. Kramer, Patricia Szot, Mark W. Hamblin	1997	42
11	Four 5‐Hydroxytryptamine₇ (5‐HT₇) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon Organization Journal of Neurochemistry ·Doris Heidmann, Mark A. Metcalf, Ruth Kohen, Mark W. Hamblin	1997	181
12	Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT₆ Serotonin Receptor Journal of Neurochemistry ·Ruth Kohen, Mark A. Metcalf, Naseem Khan, Teresa Druck, Kay Huebner, Jean E. Lachowicz, Herbert Y. Meltzer, David R. Sibley, Bryan L. Roth, Mark W. Hamblin	1996	311
13	Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor rnRNA levels in rat brain Brain Research ·John F. Neumaier, Patricia Szot, Elaine R. Peskind, Daniel M. Dorsa, Mark W. Hamblin	1996	32
14	Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with tourette syndrome Genomics ·Joel Gelernter, Peter A. Rao, David L. Pauls, Mark W. Hamblin, David R. Sibley, Kenneth K. Kídd	1995	40
15	Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Molecular Pharmacology ·Frederick J. Monsma, Yong Shen, Raymond P. Ward, Mark W. Hamblin, David R. Sibley Hit paper breakdown →	1993	512
16	Conversion of the human 5-HT1Dβ serotonin receptor to the rat 5-HT1b ligand-binding phenotype by Thr355 ASN site directed mutagenesis Biochemical Pharmacology ·Mark A. Metcalf, Robert W. McGuffin, Mark W. Hamblin	1992	60
17	Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors Molecular and Cellular Neuroscience ·Mark W. Hamblin, Robert W. McGuffin, Mark A. Metcalf, Jin Na, Lili Melva	1992	94
18	Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: A homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity Biochemical and Biophysical Research Communications ·Mark W. Hamblin, Mark A. Metcalf, Robert W. McGuffin, Allen Bowman	1992	87
19	G protein dependent alterations in [125I]iodocyanopindolol and�cyanopindolol binding at 5-HT1B binding sites in rat brain membranes Neurochemical Research ·FAYE Babacar, Mark W. Hamblin, J. Vandenbroeck, 孝子広瀬, Roland D. Ciaranello	1989	12
20	Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline Life Sciences ·Mark W. Hamblin, Ian Creese	1983	126

About Mark W. Hamblin

Mark W. Hamblin is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Molecular Biology, Developmental Neuroscience and Social Psychology, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (30 papers), Receptor Mechanisms and Signaling (25 papers), Neuroscience and Neuropharmacology Research (16 papers), Nicotinic Acetylcholine Receptors Study (7 papers), Ion channel regulation and function (4 papers), Neuroendocrine regulation and behavior (4 papers), Stress Responses and Cortisol (3 papers) and Chemical synthesis and alkaloids (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.9k citations), Behavioral Neuroscience (175 citations), Biological Psychiatry (111 citations), Molecular Biology (2.3k citations) and Psychiatry and Mental health (388 citations). Mark W. Hamblin has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include David R. Sibley, Mark A. Metcalf, Ian Creese, Frederick J. Monsma, Stuart E. Leff, Ruth Kohen, Raymond P. Ward, Yong Shen, Doris Heidmann and Yiping Shen. Their work appears in journals such as Molecular Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Biological Psychiatry, Brain Research and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact